Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine

Detalles Bibliográficos
Autores principales: Kazmi, Shayma, Chatterjee, Debanjana, Raju, Dheeraj, Hauser, Rob, Kaufman, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496657/
https://www.ncbi.nlm.nih.gov/pubmed/33907908
http://dx.doi.org/10.1007/s10549-021-06223-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496657/
https://www.ncbi.nlm.nih.gov/pubmed/33907908
http://dx.doi.org/10.1007/s10549-021-06223-6

Ejemplares similares